These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28078566)

  • 1. An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases.
    Poletti B; Carelli L; Solca F; Lafronza A; Pedroli E; Faini A; Zago S; Ticozzi N; Ciammola A; Morelli C; Meriggi P; Cipresso P; Lulé D; Ludolph AC; Riva G; Silani V
    Neurol Sci; 2017 Apr; 38(4):595-603. PubMed ID: 28078566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS.
    Poletti B; Carelli L; Solca F; Lafronza A; Pedroli E; Faini A; Ticozzi N; Ciammola A; Meriggi P; Cipresso P; Lulé D; Ludolph AC; Riva G; Silani V
    J Neurol; 2017 Jun; 264(6):1136-1145. PubMed ID: 28503706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Arrows and Colors Cognitive Test (ACCT): A new verbal-motor free cognitive measure for executive functions in ALS.
    Poletti B; Carelli L; Faini A; Solca F; Meriggi P; Lafronza A; Ciringione L; Pedroli E; Ticozzi N; Ciammola A; Cipresso P; Riva G; Silani V
    PLoS One; 2018; 13(8):e0200953. PubMed ID: 30091987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neuropsychological battery to detect specific executive and social cognitive impairments in early frontotemporal dementia.
    Torralva T; Roca M; Gleichgerrcht E; Bekinschtein T; Manes F
    Brain; 2009 May; 132(Pt 5):1299-309. PubMed ID: 19336463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive assessment in Amyotrophic Lateral Sclerosis by means of P300-Brain Computer Interface: a preliminary study.
    Poletti B; Carelli L; Solca F; Lafronza A; Pedroli E; Faini A; Zago S; Ticozzi N; Meriggi P; Cipresso P; Lulé D; Ludolph AC; Riva G; Silani V
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):473-481. PubMed ID: 27169693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis.
    Osborne RA; Sekhon R; Johnston W; Kalra S
    J Neurol Sci; 2014 Jan; 336(1-2):191-6. PubMed ID: 24239183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson's disease patients.
    Aiello EN; D'Iorio A; Solca F; Torre S; Bonetti R; Scheveger F; Colombo E; Maranzano A; Maderna L; Morelli C; Doretti A; Amboni M; Vitale C; Verde F; Ferrucci R; Barbieri S; Zirone E; Priori A; Pravettoni G; Santangelo G; Silani V; Ticozzi N; Ciammola A; Poletti B
    J Neural Transm (Vienna); 2023 May; 130(5):687-696. PubMed ID: 36976351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.
    Keller J; Gorges M; Horn HT; Aho-Özhan HE; Pinkhardt EH; Uttner I; Kassubek J; Ludolph AC; Lulé D
    J Neurol; 2015 Aug; 262(8):1918-26. PubMed ID: 26041615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Complex Interplay Between Depression/Anxiety and Executive Functioning: Insights From the ECAS in a Large ALS Population.
    Carelli L; Solca F; Faini A; Madotto F; Lafronza A; Monti A; Zago S; Doretti A; Ciammola A; Ticozzi N; Silani V; Poletti B
    Front Psychol; 2018; 9():450. PubMed ID: 29674987
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential relationship between neurological and cognitive dysfunction in first episode psychosis patients and in healthy individuals.
    Mellacqua Z; Eyeson J; Orr KD; Morgan KD; Zanelli J; Lloyd T; Morgan C; Fearon P; Hutchinson G; Doody GA; Chan RC; Harrison G; Jones PB; Murray RM; Reichenberg A; Dazzan P
    Schizophr Res; 2012 Dec; 142(1-3):159-64. PubMed ID: 23092940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological functioning in young subjects with generalized anxiety disorder with and without pharmacotherapy.
    Tempesta D; Mazza M; Serroni N; Moschetta FS; Di Giannantonio M; Ferrara M; De Berardis D
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():236-41. PubMed ID: 23796524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telephone-based Frontal Assessment Battery (t-FAB): standardization for the Italian population and clinical usability in neurological diseases.
    Aiello EN; Pucci V; Diana L; Niang A; Preti AN; Delli Ponti A; Sangalli G; Scarano S; Tesio L; Zago S; Difonzo T; Appollonio I; Mondini S; Bolognini N
    Aging Clin Exp Res; 2022 Jul; 34(7):1635-1644. PubMed ID: 35699839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine.
    Palermo L; MacDonald A; Limback E; Robertson L; Howe S; Geberhiwot T; Romani C
    J Clin Exp Neuropsychol; 2020 Mar; 42(2):142-159. PubMed ID: 31790339
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a computer-based battery designed to screen adults for neuropsychological impairment.
    Letz R; Green RC; Woodard JL
    Neurotoxicol Teratol; 1996; 18(4):365-70. PubMed ID: 8866526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in patients with stress-related exhaustion.
    Jonsdottir IH; Nordlund A; Ellbin S; Ljung T; Glise K; Währborg P; Wallin A
    Stress; 2013 Mar; 16(2):181-90. PubMed ID: 22746338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French consensus procedure for assessing cognitive function in Parkinson's disease.
    Dujardin K; Auzou N; Lhommée E; Czernecki V; Dubois B; Fradet A; Maltete D; Meyer M; Pineau F; Schmitt E; Sellal F; Tison F; Vidal T; Azulay JP; Welter ML; Corvol JC; Durif F; Rascol O;
    Rev Neurol (Paris); 2016 Nov; 172(11):696-702. PubMed ID: 27318613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post-electroconvulsive therapy multidomain cognitive assessment in psychotic depression: relationship to premorbid abilities and symptom improvement.
    Bayless JD; McCormick LM; Brumm MC; Espe-Pfeifer PB; Long JJ; Lewis JL
    J ECT; 2010 Mar; 26(1):47-52. PubMed ID: 19710624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological assessment in kidney and liver transplantation candidates.
    Lacerda SS; Guimaro MS; Prade CV; Ferraz-Neto BH; Karam CH; Andreoli PB
    Transplant Proc; 2008 Apr; 40(3):729-31. PubMed ID: 18455000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.